Market Overview

Globus Medical, Inc. Class A (NYSE: GMED)

49.26 +0.54 (1.11%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/06/20Wells FargoMaintainsOverweight56.0
8/06/20Piper SandlerMaintainsNeutral55.0
8/06/20Canaccord GenuityMaintainsBuy60.0
8/06/20Credit SuisseMaintainsOutperform58.0
8/06/20Morgan StanleyMaintainsEqual-Weight58.0
8/06/20NeedhamMaintainsBuy65.0
8/06/20SVB LeerinkMaintainsOutperform64.0
7/06/20Piper SandlerDowngradesNeutral50.0
5/08/20UBSMaintainsBuy61.0
5/08/20Credit SuisseMaintainsOutperform57.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter